Recent Posts
- Cheaper HIV treatment for children: a report in the Lancet
- European Medicines Agency approves use of Dolutegravir 5 mg dispersible tablet for younger children living with HIV
- ODYSSEY trial data published in Lancet – shows increase in treatment options for older children living with HIV
- Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial
- Dolutegravir for Children living with HIV
Recent Comments